Large
accelerated filer
|
o
|
Accelerated
filer
|
o
|
|
Non-accelerated
filer
|
o
|
Smaller
reporting company
|
þ
|
Financial
Statements.
|
MATERIAL
TECHNOLOGIES, INC.
|
||||
(A
Development Stage Company)
|
||||
CONDENSED
CONSOLIDATED BALANCE SHEET
|
||||
June
30,
|
||||
2008
|
||||
(Unaudited)
|
||||
ASSETS
|
||||
Current
assets:
|
||||
Cash
and cash equivalents
|
$ | 530,045 | ||
Inventories
|
148,964 | |||
Prepaid
expenses and other current assets
|
62,941 | |||
Total current assets
|
741,950 | |||
Property
and equipment, net
|
89,632 | |||
Intangible
assets, net
|
2,302 | |||
Deposit
|
2,348 | |||
$ | 836,232 |
MATERIAL
TECHNOLOGIES, INC.
|
||||
(A
Development Stage Company)
|
||||
CONDENSED
CONSOLIDATED BALANCE SHEET - Continued
|
||||
June
30,
|
||||
2008
|
||||
(Unaudited)
|
||||
LIABILITIES
AND STOCKHOLDERS' DEFICIT
|
||||
Current liabilities:
|
||||
Accounts payable and accrued expenses
|
$ | 470,017 | ||
Current portion of research and development sponsorship
payable
|
25,000 | |||
Notes
payable
|
67,573 | |||
Convertible debentures and accrued interest payable, net of
discount
|
3,323,466 | |||
Total current liabilities
|
3,886,056 | |||
Accrued legal settlement
|
250,000 | |||
Research and development sponsorship payable, net of current
portion
|
784,100 | |||
Convertible debentures and accrued interest payable, net of
discount
|
29,024 | |||
Notes payable, long-term
|
222,110 | |||
Derivative and warrant liabilities
|
6,439,158 | |||
7,724,392 | ||||
Total liabilities
|
11,610,448 | |||
Minority interest in consolidated subsidiary
|
825 | |||
Commitments and contingencies
|
||||
Stockholders' deficit:
|
||||
Class
A preferred stock, $0.001 par value, liquidation
preference
|
||||
of $720
per share; 350,000 shares authorized; 337 shares issued
|
||||
and
outstanding as of June 30, 2008
|
- | |||
Class
B preferred stock, $0.001 par value, liquidation preference
of
|
||||
$10,000
per share; 15 shares authorized; none issued
and
|
||||
outstanding
as of June 30, 2008
|
- | |||
Class
C preferred stock, $0.001 par value, liquidation preference
of
|
||||
$0.001
per share; 25,000,000 shares authorized; 1,517 shares
issued
|
||||
and
outstanding as of June 30,2008
|
1 | |||
Class
D preferred stock, $0.001 par value, liquidation preference
of
|
||||
$0.001
per share; 20,000,000 shares authorized; none shares
issued
|
||||
and outstanding as of June 30,2008
|
- | |||
Class
E convertible preferred stock, $0.001 par value, no
liquidation
|
||||
preference;
60,000 shares authorized; 53,700 shares issued and
|
||||
outstanding as of June 30,2008
|
54 | |||
Class A Common Stock, $0.001 par value, 600,000,000 shares
|
||||
authorized; 168,499,167 shares issued and 149,330,402 shares
outstanding
|
||||
at June 30,2008
|
149,330 | |||
Class B Common Stock, $0.001 par value, 600,000 shares
authorized,
|
||||
issued and outstanding as of June 30,2008
|
600 | |||
Warrants subscribed
|
10,000 | |||
Additional paid-in-capital
|
326,755,678 | |||
Deficit accumulated during the development stage
|
(337,594,305 | ) | ||
Treasury stock (292,977 shares at cost at June 30,2008)
|
(96,399 | ) | ||
Total stockholders' deficit
|
(10,775,041 | ) | ||
$ | 836,232 |
MATERIAL
TECHNOLOGIES, INC.
|
||||||||||||||||||||
(A
Development Stage Company)
|
||||||||||||||||||||
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
||||||||||||||||||||
From
October 21, 1983
|
||||||||||||||||||||
For
the Three Months Ended
|
For
the Six Months Ended
|
(Inception)
|
||||||||||||||||||
June
30,
|
June
30,
|
through
|
||||||||||||||||||
2007
|
2008
|
2007
|
2008
|
June
30, 2008
|
||||||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||||
(Restated)
|
(Restated)
|
|||||||||||||||||||
Revenues:
|
||||||||||||||||||||
Research
and development
|
$ | - | $ | - | $ | - | $ | - | $ | 5,392,085 | ||||||||||
Revenue
from bridge testing
|
22,778 | 66,745 | 1,090 | 319,714 | ||||||||||||||||
Other
|
- | - | - | - | 274,125 | |||||||||||||||
Total
revenues
|
22,778 | - | 66,745 | 1,090 | 5,985,924 | |||||||||||||||
Costs
and expenses:
|
||||||||||||||||||||
Research
and development
|
3,294,575 | 150,847 | 3,512,076 | 309,840 | 20,872,829 | |||||||||||||||
General
and administrative
|
41,016,474 | 5,517,443 | 62,475,638 | 25,845,768 | 329,341,009 | |||||||||||||||
Modification of research and | ||||||||||||||||||||
development sponsorship agreement
|
- | - | - | - | 5,963,120 | |||||||||||||||
Loss
on settlement of lawsuits
|
- | - | - | - | 1,267,244 | |||||||||||||||
Total
costs and expenses
|
44,311,049 | 5,668,290 | 65,987,714 | 26,155,608 | 357,444,202 | |||||||||||||||
Loss
from operations
|
(44,288,271 | ) | (5,668,290 | ) | (65,920,969 | ) | (26,154,518 | ) | (351,458,278 | ) | ||||||||||
Other
income (expense):
|
||||||||||||||||||||
Gain
on modification of convertible debt
|
- | - | - | - | 586,245 | |||||||||||||||
Loss
on subcription receivables
|
(1,368,555 | ) | ||||||||||||||||||
Interest
expense
|
(612,416 | ) | (397,973 | ) | (1,590,651 | ) | (768,964 | ) | (12,509,157 | ) | ||||||||||
Other-than-temporary
impairment of marketable
|
||||||||||||||||||||
securities
available for sale
|
- | (9,785,947 | ) | |||||||||||||||||
Net
unrealized and realized loss of marketable securities
|
(8,556,211 | ) | (8,556,219 | ) | (8 | ) | (9,398,226 | ) | ||||||||||||
Change
in fair value of investments derivative liability
|
- | - | - | - | (210,953 | ) | ||||||||||||||
Change
in fair value of derivative and warrant liabilities
|
6,942,597 | (6,036,711 | ) | 22,920,017 | 2,522,864 | 46,109,953 | ||||||||||||||
Interest
income
|
12,594 | 3,080 | 15,966 | 15,523 | 482,405 | |||||||||||||||
Other
|
- | - | - | - | (25,992 | ) | ||||||||||||||
Other
income (expense), net
|
(2,213,436 | ) | (6,431,604 | ) | 12,789,113 | 1,769,415 | 13,879,773 | |||||||||||||
Loss
before provision for income taxes
|
(46,501,707 | ) | (12,099,894 | ) | (53,131,856 | ) | (24,385,103 | ) | (337,578,505 | ) | ||||||||||
Provision
for income taxes
|
- | - | (800 | ) | (800 | ) | (15,800 | ) | ||||||||||||
Net
loss
|
$ | (46,501,707 | ) | $ | (12,099,894 | ) | $ | (53,132,656 | ) | $ | (24,385,903 | ) | $ | (337,594,305 | ) | |||||
Per
share data:
|
||||||||||||||||||||
Basic
and diluted net loss per share
|
$ | (0.45 | ) | $ | (0.08 | ) | $ | (0.58 | ) | $ | (0.17 | ) | ||||||||
Weighted
average Class A common shares
|
||||||||||||||||||||
outstanding
- basic and diluted
|
103,710,307 | 156,616,668 | 91,537,571 | 147,589,164 |
MATERIAL
TECHNOLOGIES, INC.
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
CONSOLIDATED
STATEMENTS OF COMPREHENSIVE LOSS
|
||||||||||||
From
October 21, 1983
|
||||||||||||
For
the Three Months Ended
|
(Inception)
|
|||||||||||
June
30,
|
through
|
|||||||||||
2007
|
2008
|
June
30, 2008
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
(Restated)
|
||||||||||||
Net
loss
|
$ | (46,501,707 | ) | $ | (12,099,894 | ) | $ | (337,594,305 | ) | |||
Other
comprehensive loss:
|
||||||||||||
Temporary
increase (decrease) in market
|
||||||||||||
value
of securities available for sale
|
- | - | ||||||||||
Reclassification
to other-than-temporary
|
||||||||||||
impairment
of marketable securities
|
||||||||||||
available
for sale
|
- | - | - | |||||||||
- | - | - | ||||||||||
Net
comprehensive loss
|
$ | (46,501,707 | ) | $ | (12,099,894 | ) | $ | (337,594,305 | ) |
MATERIAL
TECHNOLOGIES, INC.
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
CONDENSED
CONSOLIDATED STATEMENTS OF CASH
FLOWS
|
||||||||||||
From
October 21, 1983
|
||||||||||||
For
the Six Months Ended
|
(Inception)
|
|||||||||||
June
30,
|
through
|
|||||||||||
2007
|
2008
|
June
30, 2008
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
(Restated)
|
||||||||||||
Cash
flows from operating activities:
|
||||||||||||
Net
loss
|
$ | (53,132,656 | ) | $ | (24,385,903 | ) | $ | (337,594,305 | ) | |||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||||||
Gain
on modification of convertible debt
|
- | - | (586,245 | ) | ||||||||
Impairment
loss
|
19,255,875 | 21,391,528 | ||||||||||
Loss
on charge off of subscription receivables
|
- | 1,368,555 | ||||||||||
Issuance
of common stock for services
|
15,558,944 | 3,625,200 | 210,110,040 | |||||||||
Increase
in debt for services and fees
|
- | 1,100,000 | 5,556,625 | |||||||||
Officer's
stock based compensation
|
30,000,000 | 19,885,333 | 86,460,675 | |||||||||
Issuance
of common stock for modification of research and development
sponsorship agreement
|
- | 7,738,400 | ||||||||||
Change
in fair value of derivative and warrant liabilities
|
(41,351,889 | ) | ||||||||||
Net
realized and unrealized loss on marketable securities
|
8,556,200 | 7,895,705 | ||||||||||
Other-than-temporary
impairment of marketable securities available for
sale
|
- | 9,785,946 | ||||||||||
Legal
fees incurred for note payable
|
1,456,142 | |||||||||||
Accrued
interest expense added to principal
|
156,901 | 135,816 | 1,630,821 | |||||||||
Amortization
of discount on convertible debentures
|
1,431,081 | 632,615 | 10,738,892 | |||||||||
Change
in fair value of investments derivative liability
|
(22,920,017 | ) | (2,522,865 | ) | 700,458 | |||||||
Accrued
interest income added to principal
|
(5,428 | ) | 8,836 | (296,162 | ) | |||||||
Depreciation
and amortization
|
1,951 | 10,621 | 238,405 | |||||||||
Other
non-cash adjustments
|
- | (114,730 | ) | |||||||||
(Increase)
decrease in trade receivables
|
91,787 | 108,661 | (50,328 | ) | ||||||||
(Increase)
decrease in inventories
|
- | (86,748 | ) | (148,964 | ) | |||||||
(Increase)
decrease in prepaid expenses and other current
assets
|
(22,500 | ) | (17,257 | ) | 225,316 | |||||||
Increase
in deposits
|
- | (2,348 | ) | |||||||||
(Decrease)
increase in accounts payable and
accrued expenses
|
(141,766 | ) | (130,968 | ) | 2,377,927 | |||||||
Net
cash used in operating activities
|
(1,169,628 | ) | (1,636,659 | ) | (12,469,536 | ) | ||||||
Cash
flows from investing activities:
|
||||||||||||
Proceeds
from the sale of marketable securities
|
95,006 | 300,000 | 3,758,476 | |||||||||
Purchase
of marketable securities
|
(302,038 | ) | - | (2,206,379 | ) | |||||||
Investment
in certificate of deposits and commerical paper
|
(700,177 | ) | (565,000 | ) | (1,965,000 | ) | ||||||
Maturities
of certificate of deposits and commercial paper
|
- | 1,565,000 | 1,965,000 | |||||||||
Payment
received on officer loans
|
- | 3,803 | 880,058 | |||||||||
Funds
advanced to officers
|
- | - | (549,379 | ) | ||||||||
Proceeds
received in acquisition of consolidated subsidiaries
|
600,000 | |||||||||||
Purchase
of property and equipment
|
- | (17,167 | ) | (373,419 | ) | |||||||
Investment
in joint ventures
|
- | - | (102,069 | ) | ||||||||
Proceeds
from foreclosure
|
- | - | 44,450 | |||||||||
Proceeds
from the sale of property and equipment
|
- | - | 19,250 | |||||||||
Payment
for license agreement
|
- | - | (6,250 | ) | ||||||||
Net
cash provided by investing activities
|
(907,209 | ) | 1,286,636 | 2,064,738 |
MATERIAL
TECHNOLOGIES, INC.
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
CONSOLIDATED
STATEMENTS OF CASH FLOWS - Continued
|
||||||||||||
From
October 21, 1983
|
||||||||||||
For
the Six Months Ended
|
(Inception)
|
|||||||||||
June
30,
|
through
|
|||||||||||
2007
|
2008
|
June
30, 2008
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
(Restated)
|
||||||||||||
Cash
flow from financing activities:
|
||||||||||||
Proceeds
from the sale of common stock and warrants
|
$ | 2,850,000 | $ | 18,624 | $ | 9,464,577 | ||||||
Proceeds
from convertible debentures and other
|
||||||||||||
notes
payable
|
200,000 | 55,000 | 2,102,766 | |||||||||
Proceeds
from the sale of preferred stock
|
100,000 | - | 473,005 | |||||||||
Costs
incurred in offerings
|
(773,779 | ) | - | (1,130,932 | ) | |||||||
Capital
contributions
|
- | - | 301,068 | |||||||||
Purchase
of treasury stock
|
(17,381 | ) | (3,266 | ) | (170,641 | ) | ||||||
Principal
reduction on notes payable
|
(26,671 | ) | (100,000 | ) | ||||||||
Payment
on proposed reorganization
|
- | - | (5,000 | ) | ||||||||
Net
cash provided by (used in) financing activities
|
2,332,169 | 70,358 | 10,934,843 | |||||||||
Net
change in cash and cash equivalents
|
255,332 | (279,665 | ) | 530,045 | ||||||||
Cash
and cash equivalents, beginning of period
|
129,296 | 809,710 | - | |||||||||
Cash
and cash equivalents, end of period
|
$ | 384,628 | $ | 530,045 | $ | 530,045 | ||||||
Supplemental
disclosure of cash flow information:
|
||||||||||||
Interest
paid during the period
|
$ | 2,669 | $ | 281 | ||||||||
Income
taxes paid during the period
|
$ | 800 | $ | 800 |
Supplemental
disclosures of non-cash investing and financing
activities:
|
||||||||||||
2008
|
||||||||||||
During
the six months ended June 30, 2008, the Company issued 4,229,612 shares of
its Class A common shares in
|
||||||||||||
the
conversion of $491,132 of convertible debt.
|
||||||||||||
During
the six months ended June 30, 2008, the Company issued 13,207,500 shares
of its Class A common stock
|
||||||||||||
for
consulting services valued at $3,668,400.
|
||||||||||||
During
the six months ended June 30, 2008, the Company issued 378,491 shares of
its Class A common stock
|
||||||||||||
pursuant
to the anti-dilution provisions of a settlement agreement.
|
||||||||||||
During
the six months ended June 30, 2008. a former employee returned 450,000
shares of the Company's Class A
|
||||||||||||
common
stock to treasury which were subsequently cancelled.
|
||||||||||||
During
the six months ended June 30, 2008. the Company's president returned
30,000,000 shares of the Company's
|
||||||||||||
Class
A common stock to treasury which were subsequently
cancelled.
|
||||||||||||
During
the six months ended June 30, 2008, the Company issued 34,500,000 shares
of its Class A common stock
|
||||||||||||
in
consideration of the exercise of cashless warrants. The Company accrued
derivative liability in connection with the
|
||||||||||||
granting
of the warrants, which had a balance of $1,151,900 on the date of
exercise. The liability balance was credited to equity.
|
||||||||||||
During
the six months ended June 30, 2008, the Company issued 77,600 shares of
its Class A common stock FOR $18,624.
|
||||||||||||
During
the six months ended June 30, 2008, the Company issued 1,039,746 shares of
the Company's common stock
|
||||||||||||
was
issued through the conversion of 1,300 shares of the Company's Class E
preferred shares.
|
||||||||||||
During
the six months ended June 30, 2008, the Company contingent obligation to
Mr. Beck under a settlement agreement
|
||||||||||||
was
reduced to $0, therefore the Company reduced its legal settlement
liability by the remaining accrued provision of $230,000,
|
||||||||||||
which
was credited to equity.
|
||||||||||||
During
the six months ended June 30, 2008, the Company obtained $55,000 through
the issuance of convertible debt. In connection
|
||||||||||||
with
this debt, the Company recognized a beneficial conversion feature of
$28,140 that was credited to equity.
|
||||||||||||
During
the six months ended June 30, 2008, the Company recognized compensation
expense of $8,800 on the grant of
|
||||||||||||
options
to its employees and officers for the purchase of 800.000 shares of Class
A common stock. In addition, during the six months
|
||||||||||||
the
Company granted options to its President for the purchase of 400,000,000
shares of its Class A common stock and granted
options
|
||||||||||||
to
a consultant to purchase 15,390,546 shares of its Class A common stock.
The Company recognized a derivative liability of
$6,400,000
|
||||||||||||
on
the granting of these options.
|
||||||||||||
2007
|
||||||||||||
During
the six months ended June 30, 2007, the Company issued 2,838,598 shares of
its Class A common stock
|
||||||||||||
for
consulting services valued at $13,158,944.
|
||||||||||||
During
the six months ended June 30, 2007, the Company received $1,000,000 in
consideration of issuing 2,500,000 units.
|
||||||||||||
Each
unit consists of one share of the Company's Class A common stock and a
warrant to purchase
|
||||||||||||
one
share of the Company's common stock at a price of $.60 per share. In
connection with the private offering
|
||||||||||||
the
Company paid $239,065 in fees and issued warrants to purchase 2,118,334
shares of the Company's
|
||||||||||||
common
stock at a price of $.60 per share.
|
||||||||||||
During
the six months ended June 30, 2007, the Company issued 50,000 shares its
Class E Series convertible
|
||||||||||||
preferred
stock in exchange for receiving all of the outstanding shares of Stress
Analysis Technologies, Inc. ("SATI").
|
||||||||||||
The
Company valued the acquisition at $19,355,875 of which $19,255,875 was
allocated to the acquired license.
|
||||||||||||
Durng
the six months ended June 30, 2007, the Company deemed the license to be
impaired and charged of the
|
||||||||||||
$19,255,875
to operation. In connection with this transaction, the Company issued an
additional 5,000 preferred
|
||||||||||||
shares
valued at $2,400,000 for fees in connection with the purchase. The
$2,400,000 was charged to operations.
|
||||||||||||
During
the six months ended June 30, 2007, the Company issued 10,800,000
shares in escrow pursuant to an agreement it has with
|
||||||||||||
with
its convertible debenture holders. During 2007, 5,800,000 shares of Class
A common stock was issued to certain
|
||||||||||||
debenture
holders in the conversion of $580,000 of indebtedness. In addition,
for the redemption of 1,000,000 shares by certain
debenture
|
||||||||||||
holders,
the balance due on the debentures was increased by
$600,000.
|
||||||||||||
During
the six months ended June 30, 2007, the Company received 50,000 shares of
prior issued common stock
|
||||||||||||
which
was subsequently cancelled.
|
Finished
goods
|
$ |
142,964
|
Office
and computer equipment
|
$ | 27,645 | ||
Manufacturing
equipment
|
230,522 | |||
258,167 | ||||
Less
accumulated depreciation
|
(168,535 | ) | ||
$ | 89,632 |
Period
of
Amortization
|
|||||
Patent costs |
17
years
|
$ |
28,494
|
||
License
agreement (see Note 7)
|
17
years
|
6,250 | |||
Website
|
5
years
|
5,200 | |||
39,944 | |||||
Less
accumulated amortization
|
(37,642 | ) | |||
$ | 2,302 |
2008
|
$ 538
|
2009
|
$1,076
|
2010
|
$ 688
|
August
2,
2009
|
$ |
30,000
|
August 2,
2010
|
$ |
30,000
|
August 2, 2011 and each year thereafter
|
$ |
50,000
|
January 29, 2010
|
$ |
21,000
|
January 29, 2011
|
$ |
32,000
|
January 29, 2012
|
$ |
42,000
|
January 1, 2009
|
$ |
10,000
|
January 1, 2010
|
$ |
20,000
|
January 1, 2011 and each year thereafter
|
$ |
30,000
|
|
Fatigue Fuse
|
EFS
|
Server
Array
System
|
X-Ray
Diffraction Method
|
Nondestructive
evaluation and stimulate industrial innovation
|
|||||||||||||||
Variety
Investments, Ltd.
|
5.00 | % | - | - | - | - | ||||||||||||||
University
of Pennsylvania (see Note 7)
|
||||||||||||||||||||
Net
sales of licensed products
|
- | 7.00 | % | - | - | - | ||||||||||||||
Net
sales of services
|
- | 2.50 | % | - | - | - | ||||||||||||||
NCAT
(see Note 7)
|
||||||||||||||||||||
Net
sales of licensed products
|
- | - | 3.50 | % | - | - | ||||||||||||||
Sublicensing
income
|
- | - | 25.00 | % | - | - | ||||||||||||||
ISIS (see
Note 7)
|
||||||||||||||||||||
Net
sales of licensed products
|
- | - | - | 2.5 | % | - | ||||||||||||||
Sublicensing
income
|
- | - | - | 25.00 | % | - | ||||||||||||||
ISURF
(see Note 7)
|
||||||||||||||||||||
Net
sales of licensed products
|
- | - | - | - | 3.0 | % | ||||||||||||||
Sublicensing
income
|
- | - | - | - | 25.00 | % | ||||||||||||||
Shareholder
|
1.00 | % | 0.50 | % | - | - | - |
Issued
shares
|
168,499,167 | |||
Less
shares held in escrow:
|
||||
Shares issued to the Company and held in escrow
|
(3,357,397 | ) | ||
Shares held in escrow pursuant to agreement debenture
holders
|
(8,000,000 | ) | ||
Contingent shares held related to the Beck settlement for
antidilution purposes (see Note 10)
|
(7,805,368 | ) | ||
Other
|
(6,000 | ) | ||
19,168,765 | ) | |||
|
||||
Outstanding
shares (including shares
committed)
|
149,330,402 |
Weighed
|
||||||||
Options/
|
Average
|
|||||||
Warrants
|
Exercise
|
|||||||
Outstanding
|
Price
|
|||||||
Balance
– December 31, 2007
|
5,118,334 | $ | 0.460 | |||||
Granted
|
416,190,546 | $ | 0.006 | |||||
Exercised
|
- | - | ||||||
Forfeited
|
- | - | ||||||
Balance
– June 30, 2008
|
421,308,880 | $ | 0 .012 |
For
the Three Months Ended
|
||||||||||||||
June
30, 2007
|
||||||||||||||
As
Originally Stated
|
Adjustments
|
As
Corrected
|
||||||||||||
Revenues:
|
||||||||||||||
Research
and development
|
$ | - | - | $ | - | |||||||||
Revenue
from bridge testing
|
22,778 | 22,778 | ||||||||||||
Other
|
- | - | ||||||||||||
Total
revenues
|
22,778 | - | 22,778 | |||||||||||
Costs
and expenses:
|
||||||||||||||
Research
and development
|
2,390,415 | 1 | ) | 904,160 | 3,294,575 | |||||||||
General
and administrative
|
21,161,094 | 1 | ) | 19,855,380 | 41,016,474 | |||||||||
Total
costs and expenses
|
23,551,509 | 20,759,540 | 44,311,049 | |||||||||||
Loss
from operations
|
(23,528,731 | ) | (20,759,540 | ) | (44,288,271 | ) |
Other
income (expense):
|
||||||||||||||
Interest
expense
|
(612,416 | ) | (612,416 | ) |
Net
unrealized and realized loss of marketable securities
|
(11 | ) | 2 | ) | (8,556,200 | ) | (8,556,211 | ) | ||||||
Change
in fair value of derivative liabilities
|
791,192 | 3 | ) | 6,151,405 | 6,942,597 | |||||||||
Interest
income
|
12,594 | 12,594 | ||||||||||||
Other
expense, net
|
191,359 | (2,404,795 | ) | (2,213,436 | ) | |||||||||
Loss
before provision for income taxes
|
(23,337,372 | ) | (23,164,335 | ) | (46,501,707 | ) | ||||||||
Provision
for income taxes
|
- | - | - | |||||||||||
Net
loss
|
$ | (23,337,372 | ) | $ | (23,164,335 | ) | $ | (46,501,707 | ) | |||||
Per
share data:
|
||||||||||||||
Basic
and diluted net loss per share
|
$ | (0.23 | ) | $ | (0.22 | ) | $ | (0.45 | ) | |||||
Weighted
average Class A common shares
|
||||||||||||||
outstanding
- basic and diluted
|
103,710,307 | 103,710,307 | 103,710,307 | |||||||||||
1)
To eliminate all discounts previously used on valuing stock based
compensation.
|
||||||||||||||
2)
To eliminate discounts previously used in valuing investment in Rocket
City Automotive Group, Inc
|
||||||||||||||
3)
To eliminate discounts previously used in valuing derivative
instruments.
|
For
the Six Months Ended
|
||||||||||||||
June
30, 2007
|
||||||||||||||
As
Originally Stated
|
Adjustments
|
As
Corrected
|
||||||||||||
Revenues:
|
||||||||||||||
Research
and development
|
$ | - | - | $ | - | |||||||||
Revenue
from bridge testing
|
66,745 | - | 66,745 | |||||||||||
Other
|
- | - | - | |||||||||||
Total
revenues
|
66,745 | - | 66,745 | |||||||||||
Costs
and expenses:
|
||||||||||||||
Research
and development
|
3,402,346 | 1 | ) | 109,730 | 3,512,076 | |||||||||
General
and administrative
|
25,178,091 | 1 | ) | 37,297,547 | 62,475,638 | |||||||||
Total
costs and expenses
|
28,580,437 | 37,407,277 | 65,987,714 | |||||||||||
Loss
from operations
|
(28,513,694 | ) | (37,407,277 | ) | (65,920,969 | ) | ||||||||
Other
income (expense):
|
||||||||||||||
Gain
on modification of convertible debt
|
- | - | ||||||||||||
Modification
of research and development sponsorship agreement
|
- | - | ||||||||||||
Loss
on subscription receivable
|
- | |||||||||||||
Interest
expense
|
(1,590,651 | ) | (1,590,651 | ) | ||||||||||
Other-than-temporary
impairment of marketable
|
- | |||||||||||||
securities
available for sale
|
- | - | ||||||||||||
Net
unrealized and realized loss of marketable securities
|
(19 | ) | 2 | ) | (8,556,200 | ) | (8,556,219 | ) | ||||||
Change
in fair value of derivative liabilities
|
1,538,696 | 3 | ) | 21,381,321 | 22,920,017 | |||||||||
Interest
income
|
15,966 | 15,966 |
Other
expense, net
|
(36,008 | ) | 12,825,121 | 12,789,113 | ||||||||||